In summary, this study identifies SYDE1 as an oncogene in gliomas that can regulate the proliferation and migration of glioma cells and is predicted to interact with the SNHG16/hsa-miR-520e axis. This evidence concerns the gene SYDE1 and central nervous system cancer.